Amgen Inc (NASDAQ: AMGN)
DRUGS - Biotechnology
Health Care
Stock price data as of
Closing price: $276.39
-
Support levelN/A
-
Resistance level$281.97
-
Beta0.4
-
RSI (14-day)27.9
- AMGN is one of this month's worst performers with a return of -4.8 percent, underperforming 90 percent of stocks in the S&P-100.
- Volatility is forecast to fall over the next month.
- AMGN is below its 200-day moving average - additional caution warranted in long positions.
- With RSI < 30, AMGN is oversold. Odds slightly favor a short-term price reversal.
- Price broke below prior support level - a short-term bearish signal.
52-week low | 52-week high | Price as % of range |
---|---|---|
$258.59 | $337.38 | 25.0% |
200 day | 50 day | 20 day | 10 day |
---|---|---|---|
$287.91 | $292.75 | $287.11 | $282.00 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week6.4%
-
In the next month13.4%
-
In the next year52.0%
Period | Value |
---|---|
Historical (5 year) | 23.4% |
Last month | 23.8% |
Current estimate | 23.6% |
Next month forecast | 23.6% |